ÍøÕ¾Ê×ҳƤÑײ¡Ö¢Æ¤Ñ×Σº¦Æ¤Ñ×Ô¤·ÀƤÑ×¼ì²éƤÑ×ÖÎÁÆÆ¤Ñ×ÁÙ´²Æ¤Ñ×Òûʳ
ÄúÏÖÔÚµÄλÖ㺠±±¾©ÖÎÁÆÉñ¾­ÐÔÆ¤Ñ×|¹ýÃôÐÔÆ¤Ñ×|Ö¬ÒçÐÔÆ¤Ñ×_רÖÎÆ¤Ñ××îºÃ >> Æ¤Ñ×ÖÎÓú >> ÔçÆÚƤÑ× >> ÕýÎÄ >> ÕýÎÄ

ÔÚÍâÓÃÆ¤ÖÊÀà¹Ì´¼¼¤Ëس·Ò©¹ý³ÌÖгöÏÖµÄÑÓ³Ù

PeterGust,BS,aandSbaronE.Jacob,MDb

¸ø±à¼­µÄÐÅ£ºÎÒÃÇÔÞͬHajarµÈ1ÈËÔÚÆäÖØÒª×ÛÊöÖжÔÍâÓÃÆ¤ÖÊÀà¹Ì´¼¼¤Ëس·Ò©£¨TSW£©ºÍÉÏñ«×ÛºÏÕ÷ÎÄÏ×µÄ×ܽᡣÀà¹Ì´¼¼¤ËØÒ»Ö±ÊǸ÷ÖÖÆ¤·ô¼²²¡µÄ¾­µäÖÎÁÆÒ©Îï¡£HajarµÈ1ÈËÃèÊöµÄTSWµÄÏà¹ØÌØÕ÷Ó¡Ö¤ÁËÎÒÃǵÄÁÙ´²¾­Ñ飬°üÀ¨Ã沿µäÐͺì°ß¡¢×ÆÈÈ¡¢´ÌÍ´¸Ð£¬ÒÔ¼°Å®ÐÔΪÖ÷µÄÈË¿Úͳ¼ÆÑ§½á¹û¡£

ÎÒÃǹ۲쵽2ÀýÅ®ÐÔ²¡È˾ù³öÏÖÏàËÆµÄÉÏÊöÁÙ´²±íÏÖ£¬¶øÇÒÐèÒª¾¯ÌèµÄÊÇËýÃdzöÏÖÁËÏà¹ØµÄ³Ù·¢ÐÔ°ßÌùʵÑé·´Ó¦¡£2Àý²¡È˾ù³¤ÆÚÓÚÃæ²¿Í¿Ä¨BÀàÍâÓÃÌÇÆ¤Öʼ¤ËØ£¨Ò»ÀýΪÇú°²Ä壬ÁíÒ»ÀýΪµØÄ壩2¡£2Àý²¡È˾ù³ÊÏÖ³Ù·¢ÐÔ°ßÌùÊÔÑéÑôÐÔ½á¹û¡£µÚÒ»Àý²¡ÈËÓè0.1%Çú°²ÄεºÍ0.1%²¼µØÄε½øÐаßÌùÊÔÑ飨chemotechnique,Vellinge£¬Sweden£©£¬ÓÚ48ºÍ96Сʱ½øÐеÚÒ»´Î½á¹ûÅжÁ¡£½á¹ûÏÔʾËý¶Ô·¼Ïã»ìºÏÎï1£¨2+£©£¬Èâ¹ðÈ©£¨1+£©£¬±½¼×´¼ÑôÐÔ£¬µ«ÌÇÆ¤Öʼ¤Ëؽá¹ûΪÒõÐÔ¡£°ßÌùÎïÖÜΧÓÐÑÏÖØµÄºì°ß£¬ÓÚÊÇËý±»¸æÖªÐèÒª±ÜÃâ·¼Ïã»ìºÏÎï¡£ÎÒÃǽ¨ÒéËýÒ»µ©³öÏÖÈÎÒ½Ôº¡£°ßÌùÊÔÑé20Ììºó²¼µØÄεºÍÇú°²Äε°ßÌù´¦³öÏÖÑôÐÔ2+¡£Ëý¼ÌÐø¼ä¶ÏʹÓÃÇú°²ÄεÂÈí¸à£¬Ã沿ƤÑ×È´ÈÔδ¸ÄÉÆ¡£µÚ¶þ¸ö²¡ÈËÓÚ°ßÌùÊÔÑéÑôÐÔ21ÌìÒòÃæ²¿Ö¢×´¶ñ»¯¶ø¸´ÕÆä²¼µØÄε°ßÌù´¦³öÏÖÁËÑôÐÔ2+£¨TRUETest£¬Smartpractice£¬Phoenix£¬AZ£©¡£

Öð½¥¼õÁ¿ÍâÓõÄÌÇÆ¤Öʼ¤ËØÍ¬Ê±Ê¹Óþֲ¿µÄÃâÒßµ÷½Ú¼Áºó£¬2Àý²¡È˵ÄÁÙ´²Ö¢×´ÓÐÏÔÖøµÄ¸ÄÉÆ¡£Ò»¸ö¹ØÓÚTSWºÍÍâÓÃÌÇÆ¤Öʼ¤ËسÉñ«µÄÏàËÆÑо¿Ö¤Ã÷°´°ßÌù±ê×¼²½Öè3ʵʩÌÇÆ¤Öʼ¤ËذßÌùÊÔÑéÎÞÏà¹ØµÄÑôÐÔ½á¹û¡£ÎÒÃÇÈÏΪÐ迼ÂÇÑӳٵijٷ¢ÐÔ·´Ó¦£¨£¾7Ì죩µÄ¿ÉÄÜÐÔ¡£

ÌÇÆ¤Öʼ¤ËØËùÖ½Ӵ¥ÐÔÆ¤Ñ׿ÉÄܳ£³£´æÔÚÓÚTSW²¡ÈËÖС£ÎÒÃǽ¨ÒéÈç¹û¸ß¶È»³ÒÉTSW£¬²¡ÈËÓ¦¸Ã±ÜÃâʹÓÃÕâÀàÒ©ÎͬʱÐèÐаßÌùÊÔÑ飬²¢ÇÒÐ迼ÂÇÑӳٵijٷ¢ÐÔÑôÐÔ·´Ó¦µÄ¿ÉÄÜÐÔ£¬ÒòΪ¡°ÎÒÃDz»Ó¦¸ÃÍü¼ÇÓÃÌÇÆ¤Öʼ¤ËØÀ´ÖÎÁƱäÓ¦ÐÔ½Ó´¥ÐÔÆ¤Ñ×£¨ACD£©Ò²¿ÉÄܵ¼Ö²¡È˳öÏÖACD4¡£¡±

Fundingsources:None

Disclosures:Dr.JacobisfounderandCEOofDermatitisAcademy.Anopen-accesscontactdermatitisEsourcewitbanaffiliatedAZOVAonlineDTCteledermatologyclinicservingtheneedsofpatientswitbcontactdermatitisandservedascoordinatingprincipalinvestigatorforthesafetyandefficacyofTrueTest(SmarPractice)panels1.1,2.1,and3.1inchildrenandadolescentsandthePediatricResearchEquityAct(PREA-1)trial,andhasservedasaconsultantforjohnson

JAAD²Î¿¼ÎÄÏ×

1.HajarT,LeshemYA,HanifinJM,etal.Asystematicreviewoftopicalcorticosteroidwithdrawal(¡®¡®steroidaddiction¡¯¡¯)inpa-tientswithatopicdermatitisandotherdermatoses.JAmAcadDermatol.;72:-.

2.JacobSE,SteeleT.Corticosteroidclasses:aquickreference.JAmAcadDermatol.;54:-.

3.RapaportMJ,LebwohlM.Corticosteroidaddictionandwith-drawalintheatopic:theredburningskinsyndrome.ClinDermatol.;21:-.

4.G€on€ulM,G€ulU.Detectionofcontacthypersensitivitytocorticosteroidsinallergiccontactdermatitispatientswhodonotrespondtotopicalcorticosteroids.ContactDermatitis.;53:67-70.

E-mail:sjacob

contactderm.net

£¨Ö÷Ì⸺ÔðÈË£ºÒ¦Ö¾ÈÙ£»ÉóУ£º³ÂÌη­Ò룺ÂíÇïÓ¢»ªÖпƼ¼´óѧͬҽԺ£©

1¡¢ËÑË÷£ºÆ»¹ûÊÖ»úÔÚ¡°AppStore¡±£¬°²×¿ÊÖ»ú¿ÉÔÚ¡°ÊÖ»úÖúÊÖ¡±»ò¡°Íã¶¹¼ÔÓ¦ÓÃÊг¡¡±£¬ËÑË÷¡°Æ¤¿ÆÊ±Ñ¶ÂÛ̳¡±ÏÂÔØ°²×°¡£

2¡¢É¨Ã裺ɨÃè







































ÖпƴóÐͰ×ñ°·ç¹«ÒæÔ®Öú
°×ñ°·çÖÎÁƱê×¼

¡¾±¾ÔÂÍøÓÑºÃÆÀÍøÕ¾£º±±¾©ÖÎÁÆÉñ¾­ÐÔÆ¤Ñ×|¹ýÃôÐÔÆ¤Ñ×|Ö¬ÒçÐÔÆ¤Ñ×_רÖÎÆ¤Ñ××îºÃ¡¿
¹Ø×¢ÄÐÐÔÉúÖ³ÕûÐÎ

°Ù¶Ę̀ÖÝÄпÆÒ½Ôº±±¾©Æ¤·ô²¡×¨¿ÆÒ½ÔºÑ×»ÆÖÐÒ½Íø»¤Ê¿Ö®¼Òɽ¶«ñ²ðﲡҽԺº¼ÖÝÊÐÆ¤·ô¿Æ×¨¼ÒÁÙ´²Ñо¿°×ñ°·çר¼Ò°×ñ°·ç¿ÉÒÔÖÎÓúÂðɽ¶«°×ñ°·çÒ½Ôº

Ê×Ò³ | ÕÐÆ¸·þÎñ | ºÏ×÷»ï°é | ÓÑÇéÁ´½Ó | ¹ã¸æºÏ×÷ | ·¢²¼ÓÅÊÆ | ·þÎñÌõ¿î | Òþ˽±£»¤ | ÍøÕ¾µØÍ¼ | ÍøÕ¾¼ò½é | ³Ë³µÂ·Ïß
¹Ø×¢Æ¤·ô½¡¿µ£º±±¾©ÖÎÁÆÉñ¾­ÐÔÆ¤Ñ×|¹ýÃôÐÔÆ¤Ñ×|Ö¬ÒçÐÔÆ¤Ñ×_רÖÎÆ¤Ñ××îºÃ£¬ÓµÓÐרҵµÄÕïÁÆÍŶӣ¬°ïÄúÖÆ¶¨×î¼ÑµÄƤÑ×ÖÎÁÆ·½°¸¡£ÔÚ±¾ÍøÕ¾Äú¿ÉÒÔÈ«ÃæÁ˽â×îÐÂÉñ¾­ÐÔ£¬¹ýÃôÐÔ£¬Ö¬ÒçÐԵȸ÷ÖÖÆ¤Ñ××ÊѶ£¬¸üÓÐ×îרҵƤÑ×Ò½Éú¸úÄúÒ»¶ÔÒ»½»Á÷£¬°ïÄú´ðÒɽâ»ó£¬Ïû³ý¹ËÂÇ¡£

±±¾©ÖÎÁÆÉñ¾­ÐÔÆ¤Ñ×|¹ýÃôÐÔÆ¤Ñ×|Ö¬ÒçÐÔÆ¤Ñ×_רÖÎÆ¤Ñ××îºÃ½«ÎªÄú½éÉÜÓйؽӴ¥ÐÔÆ¤Ñ×ÔõôÖΡ¢Ã沿֬ÒçÐÔÆ¤Ñ×ͼƬ¡¢Ö¬ÒçÐÔÆ¤Ñ×´«È¾ÂðµÈƤÑ××ÉѯÐÅÏ¢¡£
±±¾©ÖÎÁÆÉñ¾­ÐÔÆ¤Ñ×|¹ýÃôÐÔÆ¤Ñ×|Ö¬ÒçÐÔÆ¤Ñ×_רÖÎÆ¤Ñ××îºÃ
Ò½ÔºµØÖ·£º±±¾©Êг¯ÑôÇøËÄ»ÝÊ¢ÊÀÁúÔ´12ºÅ
µç»°£º
ÍøÕ¾ÐÅÏ¢½ö¹©²Î¿¼£¬²»ÄÜ×÷ΪÕï¶Ï¼°Ò½ÁÆÒÀ¾Ý£¬¾ÍÒ½Çë×ñÕÕÒ½ÉúÕï¶Ï

µ±Ç°Ê±¼ä£º